Nimbus Therapeutics

About

Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.

Cambridge,Massachusetts,United States
101 - 250
http://nimbustx.com

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $125M
Industries: Biotechnology,Health Care,Therapeutics
Founded date: Jan 1, 2009
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Nimbus Therapeutics, Inc.
Also Known As: Nimbus Discovery

Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical-stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. Nimbus Therapeutics designs highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer, and immune-inflammatory disorders.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

8

$427M

Nimbus Therapeutics has raised a total of $427M in funding over 2 rounds. Their latest funding was raised on Sep 12, 2022 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 12, 2022	Series Unknown	$125M	10	—	—	Detail
Jul 13, 2021	Series Unknown	$105M	7	Biotechnology Value Fund	—	Detail
Oct 14, 2020	Series Unknown	$60M	2	—	—	Detail
Jun 5, 2018	Series C	$65M	7	SR One	—	Detail
Mar 19, 2015	Series B	$43M	6	Lightstone Ventures Pfizer Venture Investments	—	Detail

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	—	Series Unknown
Atlas Venture	—	Series Unknown
Bain Capital Life Sciences	—	Series Unknown
Bill Gates	—	Series Unknown
Biotechnology Value Fund	—	Series Unknown
Lightstone Ventures	—	Series Unknown
Pfizer Venture Investments	—	Series Unknown
RA Capital Management	—	Series Unknown
SR One	—	Series Unknown
SV Health Investors	—	Series Unknown